Therefore, it's essential to identify which driver in NASH progression impairs the anti-fibrotic effect of OCA, and the underlying mechanism may be significant in determining the efficiency of OCA in clinical practice.
← all excerpts
Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice.
1
—
—